3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD 3.750
+0.140 (3.88%)
Apr 17, 2026, 4:08 PM HKT
3D Medicines Market Cap
3D Medicines has a market cap or net worth of 920.19 million as of April 17, 2026. Its market cap has decreased by -0.92% in one year.
Market Cap
920.19M
Enterprise Value
545.20M
Revenue
396.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.75
Market Cap Chart
Since December 15, 2022, 3D Medicines's market cap has decreased from 7.02B to 920.19M, a decrease of -86.90%. That is a compound annual growth rate of -45.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 885.84M | -32.27% |
| Dec 31, 2025 | 1.31B | 73.29% |
| Dec 31, 2024 | 754.73M | -56.44% |
| Dec 29, 2023 | 1.73B | -81.75% |
| Dec 30, 2022 | 9.49B | 35.14% |
| Dec 15, 2022 | 7.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.57B |
| Kintor Pharmaceutical | 1.40B |
| Beijing Biostar Pharmaceuticals | 1.29B |
| Transcenta Holding | 1.26B |
| Shanghai Bio-heart Biological Technology | 1.02B |
| Brii Biosciences | 995.73M |
| Sunho Biologics | 970.43M |
| Wuhan YZY Biopharma | 934.35M |